{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:06:21Z","timestamp":1790075181536,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82125030, 82341022"],"award-info":[{"award-number":["82125030, 82341022"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"DOI":"10.1038\/s42255-026-01586-w","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T09:02:10Z","timestamp":1788771730000},"page":"1871-1887","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ASS1-derived argininosuccinate promotes purine nucleoside synthesis in B\u2009cell acute lymphoblastic leukaemia"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9885-311X","authenticated-orcid":false,"given":"Gen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haichuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0680-3843","authenticated-orcid":false,"given":"Cefan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0557-3097","authenticated-orcid":false,"given":"Zhenning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5524-4518","authenticated-orcid":false,"given":"Jingfeng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4218-0092","authenticated-orcid":false,"given":"Peng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"1586_CR1","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nrd2324","volume":"6","author":"A Quintas-Cardama","year":"2007","unstructured":"Quintas-Cardama, A., Kantarjian, H. & Cortes, J. Flying under the radar: the new wave of BCR\u2013ABL inhibitors. Nat. Rev. Drug Discov. 6, 834\u2013848 (2007).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1586_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev.immunol.22.012703.104753","volume":"22","author":"S Wong","year":"2004","unstructured":"Wong, S. & Witte, O. N. The BCR\u2013ABL story: bench to bedside and back. Annu. Rev. Immunol. 22, 247\u2013306 (2004).","journal-title":"Annu. Rev. Immunol."},{"key":"1586_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.molmed.2016.11.002","volume":"23","author":"KN Nelson","year":"2017","unstructured":"Nelson, K. N., Peiris, M. N., Meyer, A. N., Siari, A. & Donoghue, D. J. Receptor tyrosine kinases: translocation partners in hematopoietic disorders. Trends Mol. Med. 23, 59\u201379 (2017).","journal-title":"Trends Mol. Med."},{"key":"1586_CR4","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1126\/science.289.5486.1938","volume":"289","author":"T Schindler","year":"2000","unstructured":"Schindler, T. et al. Structural mechanism for STI-571 inhibition of abelson tyrosine kinase. Science 289, 1938\u20131942 (2000).","journal-title":"Science"},{"key":"1586_CR5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11912-001-0054-z","volume":"3","author":"MJ Mauro","year":"2001","unstructured":"Mauro, M. J. & Druker, B. J. STI571: a gene product-targeted therapy for leukemia. Curr. Oncol. Rep. 3, 223\u2013227 (2001).","journal-title":"Curr. Oncol. Rep."},{"key":"1586_CR6","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1056\/NEJMoa011573","volume":"346","author":"H Kantarjian","year":"2002","unstructured":"Kantarjian, H. et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N. Engl. J. Med. 346, 645\u2013652 (2002).","journal-title":"N. Engl. J. Med."},{"key":"1586_CR7","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1126\/science.1062538","volume":"293","author":"ME Gorre","year":"2001","unstructured":"Gorre, M. E. et al. Clinical resistance to STI-571 cancer therapy caused by BCR\u2013ABL gene mutation or amplification. Science 293, 876\u2013880 (2001).","journal-title":"Science"},{"key":"1586_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S1535-6108(02)00096-X","volume":"2","author":"NP Shah","year":"2002","unstructured":"Shah, N. P. et al. Multiple BCR\u2013ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia. Cancer Cell 2, 117\u2013125 (2002).","journal-title":"Cancer Cell"},{"key":"1586_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.115064","volume":"43","author":"Y Mao","year":"2024","unstructured":"Mao, Y., Xia, Z., Xia, W. & Jiang, P. Metabolic reprogramming, sensing, and cancer therapy. Cell Rep. 43, 115064 (2024).","journal-title":"Cell Rep."},{"key":"1586_CR10","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.cell.2012.02.032","volume":"148","author":"RJ DeBerardinis","year":"2012","unstructured":"DeBerardinis, R. J. & Thompson, C. B. Cellular metabolism and disease: what do metabolic outliers teach us? Cell 148, 1132\u20131144 (2012).","journal-title":"Cell"},{"key":"1586_CR11","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41577-024-01026-4","volume":"24","author":"M De Martino","year":"2024","unstructured":"De Martino, M., Rathmell, J. C., Galluzzi, L. & Vanpouille-Box, C. Cancer cell metabolism and antitumour immunity. Nat. Rev. Immunol. 24, 654\u2013669 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"1586_CR12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","volume":"21","author":"ZE Stine","year":"2022","unstructured":"Stine, Z. E., Schug, Z. T., Salvino, J. M. & Dang, C. V. Targeting cancer metabolism in the era of precision oncology. Nat. Rev. Drug Discov. 21, 141\u2013162 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1586_CR13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrc3038","volume":"11","author":"WH Koppenol","year":"2011","unstructured":"Koppenol, W. H., Bounds, P. L. & Dang, C. V. Otto Warburg\u2019s contributions to current concepts of cancer metabolism. Nat. Rev. Cancer 11, 325\u2013337 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"1586_CR14","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrc.2016.77","volume":"16","author":"N Hay","year":"2016","unstructured":"Hay, N. Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? Nat. Rev. Cancer 16, 635\u2013649 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"1586_CR15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cell.2006.05.036","volume":"126","author":"K Bensaad","year":"2006","unstructured":"Bensaad, K. et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126, 107\u2013120 (2006).","journal-title":"Cell"},{"key":"1586_CR16","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ncb2172","volume":"13","author":"P Jiang","year":"2011","unstructured":"Jiang, P. et al. p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nat. Cell Biol. 13, 310\u2013316 (2011).","journal-title":"Nat. Cell Biol."},{"key":"1586_CR17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41586-019-0996-7","volume":"567","author":"L Li","year":"2019","unstructured":"Li, L. et al. p53 regulation of ammonia metabolism through urea cycle controls polyamine biosynthesis. Nature 567, 253\u2013256 (2019).","journal-title":"Nature"},{"key":"1586_CR18","doi-asserted-by":"publisher","first-page":"18782","DOI":"10.1073\/pnas.0810199105","volume":"105","author":"DR Wise","year":"2008","unstructured":"Wise, D. R. et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc. Natl Acad. Sci. USA 105, 18782\u201318787 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1586_CR19","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nature07823","volume":"458","author":"P Gao","year":"2009","unstructured":"Gao, P. et al. c-Myc suppression of miR-23a\/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458, 762\u2013765 (2009).","journal-title":"Nature"},{"key":"1586_CR20","doi-asserted-by":"publisher","unstructured":"Mao, Y., Xia, W. & Jiang, P. Metabolites as signalling molecules in the tumour immune microenvironment. Nat. Rev. Immunol. 26, 422\u2013438 https:\/\/doi.org\/10.1038\/s41577-025-01258-y (2026).","DOI":"10.1038\/s41577-025-01258-y"},{"key":"1586_CR21","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1016\/j.molcel.2021.08.005","volume":"81","author":"E Hajaj","year":"2021","unstructured":"Hajaj, E., Sciacovelli, M., Frezza, C. & Erez, A. The context-specific roles of urea cycle enzymes in tumorigenesis. Mol. Cell 81, 3749\u20133759 (2021).","journal-title":"Mol. Cell"},{"key":"1586_CR22","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/s41586-023-05720-6","volume":"615","author":"A Hooftman","year":"2023","unstructured":"Hooftman, A. et al. Macrophage fumarate hydratase restrains mtRNA-mediated interferon production. Nature 615, 490\u2013498 (2023).","journal-title":"Nature"},{"key":"1586_CR23","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.molcel.2021.12.006","volume":"82","author":"Y Mao","year":"2022","unstructured":"Mao, Y., Shi, D., Li, G. & Jiang, P. Citrulline depletion by ASS1 is required for proinflammatory macrophage activation and immune responses. Mol. Cell 82, 527\u2013541.e7 (2022).","journal-title":"Mol. Cell"},{"key":"1586_CR24","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1046\/j.1432-1033.2003.03559.x","volume":"270","author":"A Husson","year":"2003","unstructured":"Husson, A., Brasse-Lagnel, C., Fairand, A., Renouf, S. & Lavoinne, A. Argininosuccinate synthetase from the urea cycle to the citrulline\u2013NO cycle. Eur. J. Biochem. 270, 1887\u20131899 (2003).","journal-title":"Eur. J. Biochem."},{"key":"1586_CR25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/ajcn\/85.1.167","volume":"85","author":"MC van de Poll","year":"2007","unstructured":"van de Poll, M. C. et al. Interorgan amino acid exchange in humans: consequences for arginine and citrulline metabolism. Am. J. Clin. Nutr. 85, 167\u2013172 (2007).","journal-title":"Am. J. Clin. Nutr."},{"key":"1586_CR26","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.trecan.2025.08.007","volume":"11","author":"J Zhou","year":"2025","unstructured":"Zhou, J., Sun, X. & Jiang, P. The emerging roles of the urea cycle in tumor microenvironment and therapies. Trends Cancer 11, 1203\u20131219 (2025).","journal-title":"Trends Cancer"},{"key":"1586_CR27","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/j.cell.2018.07.019","volume":"174","author":"JS Lee","year":"2018","unstructured":"Lee, J. S. et al. Urea cycle dysregulation generates clinically relevant genomic and biochemical signatures. Cell 174, 1559\u20131570.e22 (2018).","journal-title":"Cell"},{"key":"1586_CR28","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nature22359","volume":"546","author":"J Kim","year":"2017","unstructured":"Kim, J. et al. CPS1 maintains pyrimidine pools and DNA synthesis in KRAS\/LKB1-mutant lung cancer cells. Nature 546, 168\u2013172 (2017).","journal-title":"Nature"},{"key":"1586_CR29","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nature15529","volume":"527","author":"S Rabinovich","year":"2015","unstructured":"Rabinovich, S. et al. Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis. Nature 527, 379\u2013383 (2015).","journal-title":"Nature"},{"key":"1586_CR30","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/s42255-024-01060-5","volume":"6","author":"LQJ Lim","year":"2024","unstructured":"Lim, L. Q. J. et al. ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage response. Nat. Metab. 6, 1294\u20131309 (2024).","journal-title":"Nat. Metab."},{"key":"1586_CR31","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/s43018-020-0106-7","volume":"1","author":"R Keshet","year":"2020","unstructured":"Keshet, R. et al. Targeting purine synthesis in ASS1-expressing tumors enhances the response to immune checkpoint inhibitors. Nat. Cancer 1, 894\u2013908 (2020).","journal-title":"Nat. Cancer"},{"key":"1586_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47075-0","volume":"15","author":"H Yang","year":"2024","unstructured":"Yang, H. et al. A commensal protozoan attenuates Clostridioides difficile pathogenesis in mice via arginine-ornithine metabolism and host intestinal immune response. Nat. Commun. 15, 2842 (2024).","journal-title":"Nat. Commun."},{"key":"1586_CR33","doi-asserted-by":"publisher","unstructured":"Gorgoglione, R. et al. Glutamine-derived aspartate biosynthesis in cancer cells: role of mitochondrial transporters and new therapeutic perspectives. Cancers (Basel) 14, 245 https:\/\/doi.org\/10.3390\/cancers14010245 (2022).","DOI":"10.3390\/cancers14010245"},{"key":"1586_CR34","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.2174\/0929867311320340007","volume":"20","author":"MG Tozzi","year":"2013","unstructured":"Tozzi, M. G., Pesi, R. & Allegrini, S. On the physiological role of cytosolic 5\u2032-nucleotidase II (cN-II): pathological and therapeutical implications. Curr. Med. Chem. 20, 4285\u20134291 (2013).","journal-title":"Curr. Med. Chem."},{"key":"1586_CR35","doi-asserted-by":"publisher","first-page":"7973","DOI":"10.1016\/S0021-9258(19)40803-X","volume":"250","author":"DE Paglia","year":"1975","unstructured":"Paglia, D. E. & Valentine, W. N. Characteristics of a pyrimidine-specific 5\u2032-nucleotidase in human erythrocytes. J. Biol. Chem. 250, 7973\u20137979 (1975).","journal-title":"J. Biol. Chem."},{"key":"1586_CR36","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ccell.2018.06.003","volume":"34","author":"CL Dieck","year":"2018","unstructured":"Dieck, C. L. et al. Structure and mechanisms of NT5C2 mutations driving thiopurine resistance in relapsed lymphoblastic leukemia. Cancer Cell 34, 136\u2013147.e6 (2018).","journal-title":"Cancer Cell"},{"key":"1586_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/2049-3002-1-12","volume":"1","author":"L Zheng","year":"2013","unstructured":"Zheng, L. et al. Reversed argininosuccinate lyase activity in fumarate hydratase-deficient cancer cells. Cancer Metab. 1, 12 (2013).","journal-title":"Cancer Metab."},{"key":"1586_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.115130","volume":"44","author":"KN Dunlap","year":"2025","unstructured":"Dunlap, K. N. et al. SLC7A5 is required for cancer cell growth under arginine-limited conditions. Cell Rep. 44, 115130 (2025).","journal-title":"Cell Rep."},{"key":"1586_CR39","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41586-023-06073-w","volume":"618","author":"ZC Nwosu","year":"2023","unstructured":"Nwosu, Z. C. et al. Uridine-derived ribose fuels glucose-restricted pancreatic cancer. Nature 618, 151\u2013158 (2023).","journal-title":"Nature"},{"key":"1586_CR40","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/s42255-023-00774-2","volume":"5","author":"OS Skinner","year":"2023","unstructured":"Skinner, O. S. et al. Salvage of ribose from uridine or RNA supports glycolysis in nutrient-limited conditions. Nature Metab. 5, 765\u2013776 (2023).","journal-title":"Nature Metab."},{"key":"1586_CR41","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1126\/science.2814477","volume":"246","author":"MP King","year":"1989","unstructured":"King, M. P. & Attardi, G. Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 246, 500\u2013503 (1989).","journal-title":"Science"},{"key":"1586_CR42","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.cmet.2024.03.008","volume":"36","author":"AK Sharma","year":"2024","unstructured":"Sharma, A. K., Khandelwal, R. & Wolfrum, C. Futile cycles: emerging utility from apparent futility. Cell Metab. 36, 1184\u20131203 (2024).","journal-title":"Cell Metab."},{"key":"1586_CR43","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/ni1008-1091","volume":"9","author":"TSP Heng","year":"2008","unstructured":"Heng, T. S. P. et al. The Immunological Genome Project: networks of gene expression in immune cells. Nat. Immunol. 9, 1091\u20131094 (2008).","journal-title":"Nat. Immunol."},{"key":"1586_CR44","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio Cancer Genomics Portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401\u2013404 (2012).","journal-title":"Cancer Discov."},{"key":"1586_CR45","doi-asserted-by":"publisher","unstructured":"Jin, H. et al. Systematic transcriptional analysis of human cell lines for gene expression landscape and tumor representation. Nat. Commun. 14, 5417 https:\/\/doi.org\/10.1038\/s41467-023-41132-w (2023).","DOI":"10.1038\/s41467-023-41132-w"}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01586-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01586-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01586-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:29:50Z","timestamp":1790072990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01586-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":45,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["1586"],"URL":"https:\/\/doi.org\/10.1038\/s42255-026-01586-w","relation":{},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"assertion":[{"value":"1 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}